BMTs that are "half-matched" are effective in treating severe sickle cell disease.

Published Date: 15 Dec 2023

Patients who are not typically candidates for transplantation showed high survival rates.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Reversing the toxic relationship with high doses of chemotherapy in oncology.

2.

How a California Oncologist Making $850k Spends Money

3.

BMTs that are "half-matched" are effective in treating severe sickle cell disease.

4.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.

5.

Year in Review: Chronic Lymphocytic Leukemia


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot